Effect of Growth Hormone Therapy in Children with Prader-Willi Syndrome – Our First Experiences
Prader-Willi syndrome (PWS) is the most common cause of morbid obesity in childhood. It is the consequence of the lack of expression of genes on the paternally inherited 15q11.2-q13 region. Hyperphagia, obesity, short stature, psychomotor retardation and deterioration of behavior predominate in clin...
Main Authors: | Gordana Stipančić, Marija Požgaj Šepec, Lavinia La Grasta Sabolić |
---|---|
Format: | Article |
Language: | English |
Published: |
Sestre Milosrdnice University hospital, Institute of Clinical Medical Research
2018-01-01
|
Series: | Acta Clinica Croatica |
Subjects: | |
Online Access: | https://hrcak.srce.hr/file/317970 |
Similar Items
-
A Review of Prader–Willi Syndrome
by: Stephen Szabadi, et al.
Published: (2022-06-01) -
Prader Willy’s syndrome diagnosed in extremely obese female adolescent
by: Lešović Snežana
Published: (2017-01-01) -
Growth Hormone Therapy in Adults with Prader-Willi Syndrome
by: Karen S. Vogt, et al.
Published: (2015-04-01) -
Successful rapid weight reduction and the use of liraglutide for morbid obesity in adolescent Prader-Willi syndrome
by: Yoo-Mi Kim, et al.
Published: (2020-03-01) -
Sex hormone replacement therapy for patients with Prader-Willi syndrome
by: WANG Liang, WANG Xi, NIE Min, WU Xueyan, MAO Jiangfeng
Published: (2023-04-01)